alendronate has been researched along with Muscle Disorders in 2 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alendronate is a widely used drug for osteoporosis in the elderly and postmenopausal women." | 5.48 | Preventing muscle wasting by osteoporosis drug alendronate in vitro and in myopathy models via sirtuin-3 down-regulation. ( Chan, DC; Chiang, CK; Chiu, CY; Chiu, HC; Liu, SH; Yang, RS, 2018) |
| "Alendronate is a widely used drug for osteoporosis in the elderly and postmenopausal women." | 1.48 | Preventing muscle wasting by osteoporosis drug alendronate in vitro and in myopathy models via sirtuin-3 down-regulation. ( Chan, DC; Chiang, CK; Chiu, CY; Chiu, HC; Liu, SH; Yang, RS, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, HC | 1 |
| Chiu, CY | 1 |
| Yang, RS | 1 |
| Chan, DC | 1 |
| Liu, SH | 1 |
| Chiang, CK | 1 |
| Gerster, JH | 1 |
2 other studies available for alendronate and Muscle Disorders
| Article | Year |
|---|---|
Preventing muscle wasting by osteoporosis drug alendronate in vitro and in myopathy models via sirtuin-3 down-regulation.
Topics: Adult; Aged; Aged, 80 and over; Alendronate; Animals; Bone Density Conservation Agents; Cells, Cultu | 2018 |
Acute polyarthritis related to once-weekly alendronate in a woman with osteoporosis.
Topics: Acute Disease; Alendronate; Arthralgia; Arthritis; Drug Administration Schedule; Female; Humans; Joi | 2004 |